When federal officials inspected a facility linked to the company responsible for the recent fungal meningitis outbreak, they found crawling insects, corroding walls, and concerns about safety and quality control.
According to the Food and Drug Administration (FDA), Ameridose, a sister company of New England Compounding Center, the compound pharmacy at the center of the meningitis outbreak, failed to investigate over 50 cases of drug contamination. Additionally, the FDA reports that Ameridose also received over 30 complaints claiming that their products were either ineffective or caused serious adverse events, such as fetal distress, post-partum hemorrhaging, shortness of breath, and unresponsive patients.
The inspectors claim Ameridose failed to take inadequate measures to prevent contamination and maintain a sterile environment where their drugs were produced. Despite these findings, the FDA says the report does not represent a final agency determination.
If you believe you were affected by the recent meningitis outbreak, you already know the severity of fungal meningitis. At Edgar Snyder & Associates, we can help. Contact us for a no obligation, free legal consultation.
Call 1-866-943-3427, or fill out the form at the top right of this webpage to get started. We can answer your questions and help you determine your legal rights. Our phones answer 24/7, and time is critical. Contact us now.